In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-18 of 18 for your search:
Cancer Type/Condition:  Extrahepatic bile duct cancer
Stage/Subtype:  metastatic extrahepatic bile duct cancer
Country:  U.S.A.
Trial Type:  Treatment
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 14865, NCT01303159
2.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: BBI608-201, NCT01325441
3.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 10-131, NCT01545141
4.

Phase: Phase II
Type: Supportive care, Treatment
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: GRID, NCT00765570
5.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SPI-1620-12-202, NCT01773785
6.

Phase: Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: HSC#11140, NCT00666991
7.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Adult
Sponsor: NCI, Other
Protocol IDs: VICC GI 0906, P30CA068485, VU-VICC-GI-0906, IRB# 090432, NCT00987766
8.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-02576, UPCI 10-037, U01CA099168, CDR0000693751, PCI-10-037, 8632, NCT01282333
9.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 to 84
Sponsor: NIH WGMCC
Protocol IDs: 110131, 11-CC-0131, NCT01336985
10.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: MCC-13419, NCI-2011-0098, NCT01375699
11.

Phase: Phase I
Type: Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: WCI1907-10, NCT01434459
12.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: I 191511, NCI-2011-03568, NCT01522820
13.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: C26001, 2011-002260-24, NCT01577758
14.

Phase: Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: GC0212, NCT01640665
15.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 12-0033, NCI-2012-00585, NCT01643499
16.

Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: UPCC 09211, NCT01449864
17.

Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 to 80
Sponsor: NCI, Other
Protocol IDs: CCCWFU 59212, NCI-2013-00063, P30CA012197, NCT01766219
18.

Phase: No phase specified
Type: Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: UPCC 13910, NCT01386697
New Search